The facility was due to expire next February but has been extended to February 2023.
It comes on the back of the company’s recently completed institutional placement and share purchase plan which generated around $274 million in capital.
The company says the debt refinancing will ensure that the firm can maintain the momentum of its growth initiatives and further strengthen its balance sheet.
Shares in Invocare (ASX:IVC)are trading 2.97 per cent higher at $11.45